Low-grade systemic inflammation has been independently implicated in metabolic disorders, such as insulin resistance and T2DM, and is typically presented with elevated levels of pro-inflammatory cytokines (i.e. IL-6, TNF-α, and CRP) [28, 29]. The gene discussed is IL6; the disease is metabolic disease.